[{"id":"6a560763-6d69-46bc-8a89-f4d53df3a437","acronym":"","url":"https://clinicaltrials.gov/study/NCT01120288","created_at":"2021-01-18T04:26:41.794Z","updated_at":"2024-07-02T16:37:09.233Z","phase":"Phase 1","brief_title":"A Pilot Study of EZN-2968, an Antisense Oligonucleotide Inhibitor of HIF-1alpha, in Adults With Advanced Solid Tumors With Liver Metastases","source_id_and_acronym":"NCT01120288","lead_sponsor":"National Cancer Institute (NCI)","biomarkers":" HIF1A","pipe":"","alterations":" ","tags":["HIF1A"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e EZN-2968"],"overall_status":"Completed","enrollment":" Enrollment 10","initiation":"Initiation: 04/29/2010","start_date":" 04/29/2010","primary_txt":"","primary_completion_date":"","study_txt":" Completion: 09/24/2013","study_completion_date":" 09/24/2013","last_update_posted":"2018-07-05"},{"id":"42c0bb5b-b379-4484-bba8-a76a5bbbc332","acronym":"","url":"https://clinicaltrials.gov/study/NCT02564614","created_at":"2021-01-18T12:25:17.342Z","updated_at":"2024-07-02T16:37:13.877Z","phase":"Phase 1b","brief_title":"A Study of Hypoxia-inducible Factor 1a (HIF1A) Messenger Ribonucleic Acid (mRNA) Antagonist (RO7070179), to Demonstrate Proof-of-mechanism in Adult Participants With Hepatocellular Carcinoma (HCC)","source_id_and_acronym":"NCT02564614","lead_sponsor":"Hoffmann-La Roche","biomarkers":" VEGFA • HIF1A • AFP • CD34","pipe":"","alterations":" ","tags":["VEGFA • HIF1A • AFP • CD34"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e EZN-2968"],"overall_status":"Completed","enrollment":" Enrollment 9","initiation":"Initiation: 05/02/2016","start_date":" 05/02/2016","primary_txt":" Primary completion: 01/22/2018","primary_completion_date":" 01/22/2018","study_txt":" Completion: 01/22/2018","study_completion_date":" 01/22/2018","last_update_posted":"2018-02-15"}]